Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline
OncologiaSobre o estudo
- Desenho
- Diretriz clínica
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Reproductive biomedicine online
- Publicado em
- 15 dez 2023
- Citações
- 17
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline
Jeffrey E Roberts, Janie Benoit, Shu Foong, Julio Saumet, Ann Korkidakis, Kristin Marr, Sarah McQuillan, Nicole Todd
Descritores MeSH
- Cryopreservation
- Neoplasms
- Fertility Preservation
- Humans
- Antineoplastic Agents
- Andrology
- Male
- Canada
- Female
Veja também
Estudos relacionados
- Fertility preservation and reproduction in patients facing gonadotoxic therapies or gonadectomy: an Ethics Committee opinion
- Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations
- ESHRE good practice recommendations on fertility preservation involving testicular tissue cryopreservation in children receiving gonadotoxic therapies†
- Cancer and fertility management: FIGO best practice advice